Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malini Patel

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Disease|July 11, 2022
Clinical outcomes and immune phenotypes associated with <i>STK11</i> co-occurring mutations in non-small cell lung cancerJyoti Malhotra, Brid Ryan, Malini Patel, et al.
JTO Clinical and Research Reports|August 20, 2024
A Phase I Trial of Atezolizumab and Varlilumab in Combination With Radiation in Patients With Metastatic NSCLCJyoti Malhotra, Yong Lin, Malini Patel, et al.
Shanghai Chest|February 1, 2021
Combining radiation therapy and immunotherapy for lung cancers: a narrative reviewChirag Modi, Lyudmyla Berim, Lauren Isserow, et al.
Advances in Radiation Oncology|July 31, 2019
Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single InstitutionNikhil Yegya-Raman, Joseph Aisner, Sinae Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2024
Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) studyJyoti Malhotra, Alberto Chiappori, Naomi Fujioka, et al.
Annals of Palliative Medicine|July 15, 2021
Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-small cell lung cancerMatthew P Deek, Nikhil Yegya-Raman, Parima Daroui, et al.
Clinical Lung Cancer|August 30, 2022
A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139Fatemeh Ardeshir-Larijani, Sandra K Althouse, Ticiana Leal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 9, 2018
Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLCNikhil Yegya-Raman, Kyle Wang, Sinae Kim, et al.
Journal of Thoracic Disease|July 10, 2020
Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancerDakim K Gaines, Nikhil Yegya-Raman, Sinae Kim, et al.
Oncotarget|February 3, 2022
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. studyConnor Willis, Hillevi Bauer, Trang H Au, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Disease|July 11, 2022
Clinical outcomes and immune phenotypes associated with <i>STK11</i> co-occurring mutations in non-small cell lung cancerJyoti Malhotra, Brid Ryan, Malini Patel, et al.
JTO Clinical and Research Reports|August 20, 2024
A Phase I Trial of Atezolizumab and Varlilumab in Combination With Radiation in Patients With Metastatic NSCLCJyoti Malhotra, Yong Lin, Malini Patel, et al.
Shanghai Chest|February 1, 2021
Combining radiation therapy and immunotherapy for lung cancers: a narrative reviewChirag Modi, Lyudmyla Berim, Lauren Isserow, et al.
Advances in Radiation Oncology|July 31, 2019
Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single InstitutionNikhil Yegya-Raman, Joseph Aisner, Sinae Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2024
Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) studyJyoti Malhotra, Alberto Chiappori, Naomi Fujioka, et al.
Annals of Palliative Medicine|July 15, 2021
Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-small cell lung cancerMatthew P Deek, Nikhil Yegya-Raman, Parima Daroui, et al.
Clinical Lung Cancer|August 30, 2022
A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139Fatemeh Ardeshir-Larijani, Sandra K Althouse, Ticiana Leal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 9, 2018
Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLCNikhil Yegya-Raman, Kyle Wang, Sinae Kim, et al.
Journal of Thoracic Disease|July 10, 2020
Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancerDakim K Gaines, Nikhil Yegya-Raman, Sinae Kim, et al.
Oncotarget|February 3, 2022
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. studyConnor Willis, Hillevi Bauer, Trang H Au, et al.
Pageof 3